Guorong Fan | Pharmaceutical Analysis | Best Researcher Award

Posted on 07/02/202507/02/2025 by ScienceFather

Guorong Fan | Pharmaceutical Analysis | Best Researcher Award

Prof. Guorong Fan, Shanghai Jiao Tong University, China.

Guorong Fan is a Professor at the School of Pharmacy, Shanghai Jiao Tong University. He has led over 50 major research projects, including national initiatives on new drug development, pharmacokinetics, and traditional Chinese medicine modernization. With 140+ SCI publications, he is an authority in pharmaceutical analysis, HPLC, and LC-MS. He has collaborated internationally with institutions like UCLA and the Free University of Brussels. A distinguished editorial board member, he has mentored over 60 doctoral and master’s students and holds patents in advanced drug analysis. His contributions continue to impact the global pharmaceutical research community.

Publivation Profiles

SCOPUS

Education and Experience

Education:

Ph.D. in Pharmaceutical Sciences
M.Sc. in Pharmacy
B.Sc. in Pharmacy

Professional Experience:

Professor, School of Pharmacy, Shanghai Jiao Tong University
Led 50+ major research projects in drug metabolism & kinetics
Published 140+ SCI papers in top journals
Editorial board member of leading pharmaceutical journals
Conducted collaborative research with UCLA & Free University of Brussels

Suitability summary

Professor Guorong Fan, a distinguished researcher at the School of Pharmacy, Shanghai Jiao Tong University, is a highly suitable candidate for the Best Researcher Award due to his groundbreaking contributions to pharmaceutical analysis, pharmacokinetics, and clinical pharmacy. With a prolific academic career spanning over 140 SCI publications, he has significantly advanced the fields of drug metabolism, bioavailability evaluation, and innovative analytical techniques. His work has shaped global pharmaceutical research and development, making him a leading figure in the industry.

Professional Development

Guorong Fan has played a crucial role in advancing pharmaceutical sciences through international collaborations, drug formulation studies, and pharmacokinetics research. His expertise in HPLC, LC-MS, and clinical drug monitoring has led to high-impact innovations in the field. As an editorial board member, he ensures the quality and integrity of pharmaceutical research publications. Additionally, his work on preclinical drug metabolism and kinetic studies has contributed to several drug approvals. Through mentorship and industry partnerships, he continues to shape the future of pharmaceutical analysis and drug development globally.

Research Focus

Guorong Fan’s research focuses on pharmaceutical analysis, pharmacokinetics, and clinical pharmacy. He specializes in drug metabolism and kinetics, particularly in HPLC and LC-MS techniques for precise drug concentration measurement. His research includes bioavailability evaluation, therapeutic drug monitoring, and analytical pharmacology. By leveraging cutting-edge analytical methods, he has contributed to the modernization of traditional Chinese medicine and innovative drug development. His studies on anti-tuberculosis and anti-AIDS drug pharmacokinetics have had a significant global impact. Through international collaborations, his work continues to drive advancements in drug analysis and personalized medicine.

Awards And Honours

Best Researcher Award
Expert Reviewer for the National Natural Science Foundation of China
Vice Chairman, Home Pharmacy Service Pharmacist Branch, Chinese Pharmacist Association
Executive Member, Drug Evaluation Committee, Chinese Research Hospital Association
Chairman, Drug Analysis Professional Committee, Shanghai Pharmaceutical Society
Editorial Board Member, Chinese Journal of New Drugs & Clinical Medicine
Recipient of multiple national and international research grants
Leader in over 50 major pharmaceutical research projects
Contributor to drug policy and development in China
Recognized for mentoring over 60 Ph.D. and master’s students

Publication Top Noted

Differences in hypersensitivity reactions and gadolinium deposition disease based on global databases – BMC Medicine, 2024 – Cited by: 1
Five years of safety profile of bevacizumab: pharmacovigilance and RCT analysis – Journal of Pharmaceutical Health Care and Sciences, 2024 – Cited by: 5
Advances in therapeutic drug monitoring of invasive fungal disease – China Pharmacy, 2024
Altered biliary microbial and metabolic profile in NAFLD and cholelithiasis – Clinics and Research in Hepatology and Gastroenterology, 2024
Cost-utility analysis and drug pricing for tirzepatide vs. semaglutide in China – Diabetes, Obesity and Metabolism, 2024 – Cited by: 2
Mining of anaphylaxis associated with oxaliplatin using FDA adverse event database – Chinese Journal of Hospital Pharmacy, 2024

Simi Pushpan | Drug Design | Best Researcher Award

Posted on 18/10/202418/10/2024 by ScienceFather

Simi Pushpan | Drug Design | Best Researcher Award

Dr. Simi Pushpan, Union Christian College Aluva, India.

Dr. Simi Pushpan is an accomplished Assistant Professor in the Department of Chemistry at Union Christian College, Aluva, Kerala. With a rich academic background, she holds a Ph.D. in Bio-Inorganic/Organic Chemistry from IIT Kanpur and has completed a prestigious Alexander von Humboldt Fellowship in Germany. Her research focuses on drug design and synthesis, particularly in developing antitumor therapeutic agents. In addition to her teaching, she has significant industry experience in medicinal chemistry, contributing to major pharmaceutical companies. Dr. Pushpan’s work has earned her numerous accolades, including the IUPAC Prize for Young Chemists. 👩‍🔬

Publication profile

Googlescholar

Scopus

Education

Ph.D. in Bio-Inorganic/Organic Chemistry
Indian Institute of Technology, Kanpur, India (2001)
M.Sc. in Chemical Sciences
Pondicherry Central University, India (1996)
B.Sc. in Chemistry
Union Christian College, Aluva, India (1994)
Postdoctoral Fellowship
Alexander von Humboldt Fellowship, Universität Regensburg, Germany (2003)

Experience

Assistant Professor
Union Christian College, Aluva, Kerala (2013–Present)
Principal Research Investigator
Biocon-Bristol Myers Squibb Research Centre, Bangalore (2009–2013)
Senior Research Scientist
Orchid Research Laboratories, Chennai (2005–2009)
Post-doctoral Fellow
Orchid Chemicals & Pharmaceuticals, Chennai (2004–2005)

Suitability for The Award

Dr. Simi Pushpan K is highly suitable for the Best Researcher Award due to her substantial contributions to the field of chemistry, particularly in bio-inorganic and organic chemistry. Her academic and industrial experiences showcase her dedication to research, teaching, and innovation.

Professional Development ()

Dr. Pushpan is dedicated to professional growth and mentoring within the academic and scientific community. As a co-convener of the Chemical Research Society of India (CRSI) Local Chapter and a member of various academic committees, she plays a vital role in shaping the curriculum and research direction at both state and national levels. Her contributions include coordinating environmental studies programs and overseeing quality assurance initiatives at Union Christian College. Dr. Pushpan’s expertise in drug design and synthesis has positioned her as a key figure in both academic and industrial research.

Research Focus

Dr. Simi Pushpan’s research primarily revolves around drug design and synthesis, focusing on developing novel therapeutic agents with potential applications in photodynamic therapy and cancer treatment. Her work on platinum(II) complexes and core-modified porphyrinoids has made significant strides in the field of medicinal chemistry. She employs various in vitro assays and cutting-edge techniques to explore the cytotoxic and phototoxic properties of synthetic compounds. Dr. Pushpan’s interdisciplinary approach integrates chemistry, biology, and pharmacology to address contemporary health challenges.

Awards and Honors ()

IUPAC Prize for Young Chemists (2002)
Star Award (Bristol Myers Squibb, 2012)
Inventor Award (Orchid Pharma, 2005-2006)
Alexander von Humboldt Fellowship (2002-2003)
CSIR Fellowship (JRF and SRF for Ph.D. program)

Publication

Porphyrins in photodynamic therapy – a search for ideal photosensitizers (332 citations, 2002)
Tetrathia-and tetraoxarubyrins: aromatic, core-modified, expanded porphyrins (92 citations, 1997)
34π Octaphyrin: first structural characterization of a planar, aromatic [1.0. 1.0. 1.0. 1.0] Octaphyrin with inverted heterocyclic rings (77 citations, 2001)
N-Confused expanded porphyrin: first example of a modified sapphyrin with an inverted n-confused pyrrole ring (75 citations, 2001)
Inverted meso-Aryl Porphyrins with Heteroatoms; Characterization of Thia, Selena, and Oxa N-Confused Porphyrins (70 citations, 2001)
Structural characterization of meso aryl sapphyrins (57 citations, 1999)
meso-Aryl sapphyrins with heteroatoms; synthesis, characterization, spectral and electrochemical properties (55 citations, 1999)
Meso aryl heptaphyrins: the first 30π aromatic expanded porphyrins with an inverted structure (49 citations, 2000)

Nikolina Kastratović | Pharmacology | Best Researcher Award

Posted on 11/09/202411/09/2024 by ScienceFather

Nikolina Kastratović | Pharmacology | Best Researcher Award

Ms. Nikolina Kastratović , Faculty of medical sciences, Serbia .

Nikolina Kastratović is a dedicated Master of Pharmacy with diverse expertise in biomedical engineering and regenerative medicine. Currently a Teaching Assistant at the Faculty of Medical Sciences, University of Kragujevac, she has contributed to several international research projects focused on chronic inflammatory diseases. A recipient of multiple awards, including the Young Talents 2023 COEHAR Award, Nikolina has published extensively in the field of pharmacology. Her innovative approach, attention to detail, and teamwork skills define her as a promising young researcher in clinical trials and pharmacological sciences.

Publication Profile

Orcid

Suitability For The Award

Nikolina Kastratović is an exceptionally qualified candidate for the Best Researcher Award, given her substantial contributions to the field of pharmacology and regenerative medicine. Her work is highly relevant, focusing on systemic inflammation, cancer research, and chronic diseases

Education and Experience

PhD / 2019-present / Faculty of Medical Sciences, University of Kragujevac
Master of Biomedical Engineering / 2020-2022 / University of Kragujevac
Master of Regenerative Medicine / 2020-2022 / University of Kragujevac
Master of Pharmacy / 2014-2019 / University of Kragujevac
Junior Researcher / 2020-2023 / Faculty of Medical Sciences, University of Kragujevac
Teaching Assistant / 2023-present / Faculty of Medical Sciences, University of Kragujevac

Professional Development

Nikolina Kastratović is actively involved in research on chronic inflammatory diseases, particularly COPD, diabetes, and inflammatory bowel diseases. Her work has earned recognition, including an award for the Best Scientific Paper in Basic Science in 2023. Nikolina has also been honored with the prestigious Young Talents 2023 COEHAR Award. She has contributed to multiple international scientific projects, displaying her commitment to improving therapeutic approaches for inflammatory conditions. Her participation in clinical trials and publication of research papers underline her growth and development as a researcher.

Research Focus

Nikolina Kastratović focuses her research on chronic inflammatory diseases, particularly exploring the impact of combustible cigarettes and electronic nicotine delivery systems on conditions such as COPD and ulcerative colitis. Her studies investigate immune cell-driven inflammation, mucosal healing, and the effects of various nicotine products on respiratory and systemic inflammation. In addition, her research encompasses innovative modeling approaches for cancer viability and drug resistance. Through her interdisciplinary work in pharmacology and bioengineering, Nikolina aims to advance understanding and treatment strategies for complex inflammatory and oncological diseases.

Awards and Honours

Best Scientific Paper Award (Basic Science) / Faculty of Medical Sciences, University of Kragujevac, 2023
Young Talents 2023 Award / COEHAR (Center of Excellence for the Acceleration of Harm Reduction), Catania, Italy
Young Researcher / Two International Scientific Projects, ongoing

Publications

Effects of Combustible Cigarettes and Heated Tobacco Products on Systemic Inflammatory Response in Patients with Chronic Inflammatory Diseases / 2024 / Cited by: Crossref / DOI: 10.3390/diseases12070144
Machine Learning Model for Prediction of Development of Cancer Stem Cell Subpopulation in Tumors Subjected to Polystyrene Nanoparticles / 2024 / Cited by: Crossref / DOI: 10.3390/toxics12050354
Modeling 5-FU-Induced Chemotherapy Selection of a Drug-Resistant Cancer Stem Cell Subpopulation / 2024 / Cited by: Crossref / DOI: 10.3390/curroncol31030091
Effects of Combustible Cigarettes and Electronic Nicotine Delivery Systems on the Development and Progression of Chronic Lung Inflammation in Mice / 2023 / Cited by: Crossref / DOI: 10.1093/ntr/ntad235
Combined Biological and Numerical Modeling Approach for Better Understanding of the Cancer Viability and Apoptosis / 2023 / Cited by: Crossref / DOI: 10.3390/pharmaceutics15061628

Conclusion

Nikolina Kastratović’s research excellence, innovative methodologies, and significant contributions to understanding chronic diseases and cancer make her a standout candidate for the Best Researcher Award. Her achievements not only advance scientific knowledge but also demonstrate her commitment to improving public health through impactful research.